Answers are grounded in this paper and cite their sources.
To the Editor. —The presence of antibodies to human T-cell lymphotropic virus type III (HTLV-III) has been studied in patients affected by acquired immunodeficiency syndrome (AIDS), AIDS-related complex, lymphadenopathy syndrome, in symptom-free individuals at high risk of developing AIDS, and in the general population."The presence of antibodies to HTVL-III in intravenous drug abusers (IDAs) has been reported as showing great geographic differences, from 87% in the United States5to 1.5% in the United Kingdom.3 In this letter, we report the preliminary results of a study of 92 consecutive heterosexual IDAs who were residents of metropolitan Barcelona, Spain, and admitted to our hospital because of infectious complications or for treatment of their drug addiction. All HTLV-III seropositive and sero-negative IDAs usually shared needles on more than one occasion. All patients were living in metropolitan Barcelona during their drug-abuse period. It is very improbable that they used needles from
No takes yet. Share an insight, caveat, or question.
Jordi Tor (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: